- Nedaplatin
-
Nedaplatin Systematic (IUPAC) name Diammine[(hydroxy-κO)acetato(2-)-κO]platinum Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ℞ Prescription only Routes IV Identifiers CAS number 95734-82-0 ATC code None PubChem CID 6917890 UNII 8UQ3W6JXAN KEGG D01416 Chemical data Formula C2H8N2O3Pt Mol. mass 303.17 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum compound which is used for cancer chemotherapy.[1] It produces less nausea, vomiting and nephrotoxicity than other platinum-containing drugs.[2]
References
- ^ Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab (2010). "The status of platinum anticancer drugs in the clinic and in clinical trials". Dalton Transactions 39 (35): 8113–27. doi:10.1039/C0DT00292E. PMID 20593091.
- ^ Ota K (February 1996). "[Nedaplatin]" (in Japanese). Gan to Kagaku Ryoho 23 (3): 379–87. PMID 8712835.
- (Japanese) Aqupla アクプラ (PDF) Shionogi & Co. March 2007.
External links
- (Japanese) Official Shionogi & Co. Website
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.